- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 2, 2025 | 26.62M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $253.07M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $253.02M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $696.81M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $656.99M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $803.44M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $751.69M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.28B |
| Current Assets | Q3 2025 · Mar 31, 2024 | $1.27B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $1.77B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $1.65B |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 26.7M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 26.67M sh |
| Stock Repurchased | Q3 2025 · Dec 31, 2023 | $9.82M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | $143.49M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $877.75M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | $845.7M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $813.29M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $782.27M |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $1.02 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $3.52 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $1.02 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $3.53 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $89.38M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $272.33M |
| Net Income | Q3 2025 · Dec 31, 2023 | $27.28M |
| Net Income | Q3 2025 · Dec 31, 2023 | $93.79M |
| Net Income | Q3 2025 · Sep 30, 2023 | $32.66M |
| Net Income | Q3 2025 · Jun 30, 2023 | $33.85M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $38.05M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $129.24M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $133.81M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $420.45M |